Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety

European Journal of Pediatrics

Volumn 174, Issue 8, 2015, Pages 1109-1115

  Tan, Kenneth ^a,b   Krishnamurthy, Mohan B ^a   O’Heney, Josie L ^a   Paul, Eldho ^b   Sehgal, Arvind ^a,b  

^a MONASH CHILDREN S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Cardiac; Echocardiography; Efficacy; Safety; Sildenafil

Indexed keywords

OXYGEN; SILDENAFIL; PHOSPHODIESTERASE V INHIBITOR;

ABSENCE OF SIDE EFFECTS; ARTICLE; ARTIFICIAL VENTILATION; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ENDOTRACHEAL INTUBATION; FEMALE; HEART RIGHT VENTRICLE PRESSURE; HOME OXYGEN THERAPY; HUMAN; INFANT; INFANT MORTALITY; LUNG DYSPLASIA; MALE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVOR; TREATMENT OUTCOME; BLOOD PRESSURE; COMPLICATION; DRUG EFFECTS; ECHOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION, PULMONARY; NEWBORN; PATHOPHYSIOLOGY; TIME FACTOR;

BLOOD PRESSURE; BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; PHOSPHODIESTERASE 5 INHIBITORS; RETROSPECTIVE STUDIES; SILDENAFIL CITRATE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84938285526     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-015-2515-7     Document Type: Article

References (25)

1. An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, Kim HS, Choi JH, Noh CI, Yun YS (2010) Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 40:131–136
2. Barst RJ (1986) Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest 89:497–503
3. Barst RJ, Maislin G, Fishman AP (1999) Vasodilator therapy for primary pulmonary hypertension in children. Circulation 99:1197–1208
4. Berman W, Yabek SM, Dillon T, Burstein R, Corlew S (1982) Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. Pediatrics 70:708–712
5. Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N (2012) Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 129:e682–e689
6. de Visser YP, Walther FJ, Laghmani EH, Boersma H, van der Laarse A, Wagenaar GTM (2009) Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res 10:30
7. Evans NJ, Archer LN (1999) Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. Arch Dis Child 66:6–11
8. Fang AY, Guy KJ, König K (2013) The effect of sildenafil on retinopathy of prematurity in very preterm infants. J Perinatol 33:218–221
9. Fouron JC, Le Guennec JC, Villemant D, Perreault G, Davignon A (1980) Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics 65:529–535
10. Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353:2148–2157
11. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I (2005) Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 111:3274–3280
12. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723–1729
13. Khemani E, McElhinney DB, Rhein L, Andraade O, Lacro RV, Thomas KC, Mullen MP (2007) Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120:1260–1269
14. King ME, Braun H, Goldblatt A, Liberthson R, Weyman AE (1983) Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation 68:68–75
15. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, The’baud B (2005) Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172:750–756
16. Lau EMT, Manes A, Celermajer DS, Galie N (2011) Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J 32:2489–2498
17. Mourani PM, Sontag MK, Ivy DD, Abman SH (2009) Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 154:379–384
18. Mourani PM1, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH (2015) Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 91(1):87–95
19. Musewe NN, Poppe D, Smallhorn JF (1990) Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn. J Am Coll Cardiol 15:446–456
20. Nyp M, Sandritter T, Poppinga N, Simon C, Truog WE (2012) Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits? J Perinatol 32:64–69
21. Sivaswamy L, Vanstavern GP (2007) Ischemic optic neuropathy in a child. Pediatr Neurol 37:371–372
22. Samiee-Zafarghandy S, Smith PB, van den Anker JN (2014) Safety of sildenafil in infants. Pediatr Crit Care Med 15:362–368
23. Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA (2011) Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 31:635–640
24. Stuart BD, Sekar P, Coulson JD, Choi SE, McGrath-Morrow SA, Collaco JM (2013) Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension. J Perinatol 33:543–547
25. Ziino AJA, Ivanovska J, Belcastro R, Kantores C, Xu EZ, Lau M, McNamara PJ, Tanswell AK, Jankov RP (2010) Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia. Pediatr Res 67:177–182